Posted: 23rd July 2018
Abingdon Health is pleased to announce the availability of a new ‘off the shelf’ lateral flow reader, the ADxLR5® Developer.
During the early stages of developing a lateral flow assay, the use of a reader is an essential tool. Whether the assay is quantitative, semi-quantitative, or qualitative, the CE marked ADxLR5® Developer is the perfect solution for assay development.
The ADxLR5® Developer analyses the lateral flow assay and provides an on-screen intensity profile of the test lines and control line and displays a picture of the LFD. The data points can be exported to a standard Excel data package for further interpretation and analysis.
The CE marked ADxLR5® Developer is engineered to be compatible with a wide range of lateral flow assay types, e.g. competitive or sandwich assay formats, gold, carbon or coloured latex particles, and can be used across different industry sectors.
Fiona Smith, Sales and Marketing Director of Abingdon Health, commented:
“We are delighted to introduce this new reader into our product portfolio. We know from our own assay development experience that using a reader during the development of a new lateral flow assay provides robust data to aid the whole process. By providing the ADxLR5® Developer other companies and researchers who are active in the field of lateral flow immunoassay development have access to this essential tool.”
For companies interested in incorporating the ADxLR5® Developer into their assay development project please contact a member of our team on +44 (0) 1904 406082 or at email@example.com.
Abingdon Health is a UK-based developer and manufacturer of lateral flow immunoassay tests and readers.
Abingdon Health offers development and manufacturing services for customers looking to develop new assays or looking to transfer existing laboratory-based assays to a lateral flow format. Abingdon Health takes projects from initial concept through to routine and large-scale manufacturing. Abingdon’s patented lateral flow reader, the ADxLR5®, is CE marked and FDA registered and can be fully customised to meet the needs of clients looking for a quantitative solution for a lateral flow assay. Internally Abingdon Health is focused on developing lateral flow assays in partnership with key opinion leaders that meet significant unmet needs
© Abingdon Health 2018